Single and Dual Chamber Leadless Pacemaker Systems, only from Abbott
.png)
Learn more about how the Single and Dual Chamber Leadless Pacemakers (LPs) from Abbott have helped patients with a broad spectrum of health concerns live healthier, better lives.
AVEIR™ VR Ventricular LP is an appropriate choice for patients indicated for permanent pacing but who may need temporary or interim pacing support following certain types of procedures like laser lead extractions (LLEs) and TAVR. For these patients, AVEIR offers:
“Real World” Abbott AVEIR VR Leadless Pacemaker Case-October 2022 (post-TAVR)
AVEIR VR Patient Selection and Implant Considerations (post-infection and LLE)
“Real World” Abbott AVEIR VR LP Case (active patient, post-LLE, post-infection)
Post-infection and post-LLE patient indicated for dual chamber
Patient with endocarditis/sepsis and intermittent CHB
Patient with permanent AF (tortuous access)
“Real World” Abbott AVEIR VR Leadless Pacemaker Case-October 2022 (post-TAVR)
AVEIR VR Patient Selection and Implant Considerations (post-infection and LLE)
“Real World” Abbott AVEIR VR LP Case (active patient, post-LLE, post-infection)
Post-infection and post-LLE patient indicated for dual chamber
Patient with endocarditis/sepsis and intermittent CHB
Patient with permanent AF (tortuous access)
Symptomatic AV Block
For patients with symptomatic AV block who have persistent atrial fibrillation (AF) or other atrial tachyarrhythmia (AT), AVEIR VR Ventricular LP can provide:
AVEIR VR Patient Selection and Implant Considerations (Young, Malignant Bradycardia)
AVEIR VR Patient Selection and Implant Considerations (higher risk, AF slow VR)
AVEIR VR Patient Selection and Implant Considerations (Young, Malignant Bradycardia)
AVEIR VR Patient Selection and Implant Considerations (higher risk, AF slow VR)
Persistent Atrial Fibrillation
Patients in this category may experience symptomatic pauses secondary to persistent or chronic atrial fibrillation, slow ventricular response or malignant tachy-brady syndrome, severe comorbidities like end-stage kidney disease1 (ESKD), or access and mobility problems that would support leadless pacing as the preferred pacing option.
AVEIR VR Ventricular LP is an appropriate option for these patients because:
Patients with sick sinus and intact AV conduction can benefit from an atrial-only, leadless pacing option that is upgradeable, retrievable, and will not contribute to additional risks associated with lead- and pocket-related complications when compared with transvenous devices.3,4
AVEIR™ AR Atrial LP provides:
Testimonials
Advantages of the AVEIR VR Leadless Pacemaker (LP): LP Case Study Presentation
Advantages of the AVEIR VR Leadless Pacemaker (LP): LP Case Study Presentation
References
For additional information about specific MR Conditional, including warnings, precautions, adverse conditions to MRI scanning and potential adverse events, please refer to the MRI-Ready Leadless Systems Manual at medical.abbott/manuals or check our MRI-Ready resources at cardiovascular.abbott/mriready.
MAT-2302697 v5.0 | Item is approved for U.S. use only
Stay Connected